Effect of isatin, an endogenous MAO inhibitor, on acetylcholine and dopamine levels in the rat striatum.

被引:0
|
作者
Hamaue, N [1 ]
Yamazaki, N
Minami, M
Endo, T
Hirafuji, M
Monma, Y
Togashi, H
Saito, H
Parvez, SH
机构
[1] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Dept Pharmacol, Ishikari, Hokkaido 06102, Japan
[2] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Dept Clin Pharmacol, Ishikari, Hokkaido 06102, Japan
[3] Hokkaido Univ, Coll Med Technol, Sapporo, Hokkaido 060, Japan
[4] Hokkaido Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido 060, Japan
[5] CNRS, Inst Alfred Fossard Neurosci, F-75700 Paris, France
关键词
isatin; endogenous MAO inhibitor; dopamine; acetylcholine; striatum;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Isatin, an endogenous inhibitor of monoamine oxidase (MAO), has several physiological properties for stress and anxiety following extensive experimental and clinical investigations. We previously identified isatin in the urine and brain of stroke-prone spontaneously hypertensive rats (SHRSP) using gas chromatography mass spectrometry. Lately, isatin was reported to have an inhibitory effect on acetylcholinesterase (AChE). This study elucidated the effect of isatin administered exogenously on the acetylcholine (ACh), choline (Ch) and dopamine (DA) levels of brain tissues in rats. Two hours after intraperitoneal administration of isatin (50 mg or 200 mg), striatal ACh, Ch and DA levels significantly increased Isatin (10(-6) M or 10(-4) M) administration through microdialysis also induced a significant increase in the ACh and DA concentration of perfusate from the rat striatum in a concentration-dependent manner. We were the first to show that isatin significantly increased ACh and DA levels in the rat striatum. These results suggest that endogenous isatin may play a role in regulating the brain levels of ACh with increasing the level of DA.
引用
收藏
页码:367 / 377
页数:11
相关论文
共 50 条
  • [1] Phosphorylation of dopamine transporters in rat striatum.
    Vaughan, R
    Huff, R
    Uhl, G
    Kuhar, M
    FASEB JOURNAL, 1996, 10 (03): : 883 - 883
  • [2] Isatin, an endogenous MAO inhibitor, improves bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by Japanese encephalitis virus
    Ogata, A
    Hamaue, N
    Terado, M
    Minami, M
    Nagashima, K
    Tashiro, K
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 206 (01) : 79 - 83
  • [3] Possible synergies between isatin, an endogenous MAO inhibitor, and antiparkinsonian agents on the dopamine release from striatum of freely moving rats
    Faro, Lilian R. F.
    Justo, Lorenzo A.
    Alfonso, Miguel
    Duran, Rafael
    NEUROPHARMACOLOGY, 2020, 171
  • [4] Isatin, an endogenous MAO inhibitor, increases ACh and DA in rat brain
    Hamaue, N
    Yamazaki, N
    Terado, M
    Minami, M
    Endo, T
    Hirafuji, M
    Monma, Y
    Togashi, H
    Honma, S
    Tashiro, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R71 - R71
  • [5] Pharmacological role of isatin, an endogenous MAO inhibitor
    Hamaue, N
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2000, 120 (04): : 352 - 362
  • [6] The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum
    Jalkanen, Aaro J.
    Piepponen, T. Petteri
    Hakkarainen, Jenni J.
    De Meester, Ingrid
    Lambeir, Anne-Marie
    Forsberg, Markus M.
    NEUROCHEMISTRY INTERNATIONAL, 2012, 60 (03) : 301 - 309
  • [7] Significance of isatin, an endogenous MAO inhibitor, on blood pressure control and monoamine levels in rats
    Hamaue, N
    Minami, M
    Hirafuji, M
    Monma, Y
    Yamazaki, N
    Togashi, H
    Saito, H
    Parvez, SH
    BIOGENIC AMINES, 1996, 12 (05) : 395 - 405
  • [8] Effects of selegiline and isatin, an endogenous MAO inhibitor, on the motor activity and dopamine levels of Japanese encephalitis-induced parkinsonism in rats
    Hamaue, N
    Terado, M
    Ogata, A
    Endo, T
    Hirafuji, M
    Tashiro, K
    Minami, M
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 95P - 95P
  • [9] Change of DA turnover in striatum by isatin, an endogenous MAO inhibitor, in rat model for Parkinson's disease induced by Japanese encephalitis virus.
    Terado, M
    Hamaue, N
    Ogata, A
    Endo, T
    Hirafuji, M
    Ohno, K
    Ide, H
    Minami, M
    Tashiro, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 189P - 189P
  • [10] SEROTONERGIC EFFECTS OF ISATIN - AN ENDOGENOUS MAO INHIBITOR RELATED TO TRIBULIN
    MCINTYRE, IM
    NORMAN, TR
    JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1990, 79 (1-2) : 35 - 40